Your veterinarian probably calls it "laser therapy" or "cold laser," but it's the same thing people market to humans as red light therapy: light in the red and near-infrared range aimed at tissue to ease pain and speed healing. The clinical name is photobiomodulation, or PBM, and over the last decade a handful of real controlled trials have tested it in dogs rather than just lab dishes. This review walks through what those dog trials actually found, which results held up, which didn't, and where the honest answer is still "we don't know."
What red light therapy for dogs actually is
Red light therapy, low-level laser therapy (LLLT), cold laser, and photobiomodulation therapy (PBMT) all describe the same basic idea. A device emits light, usually somewhere between 600 and 980 nanometers (nm), and the light is held against or near the skin over an injury, joint, or surgical site. There's no heat felt by the animal in the low-power versions, which is why it earned the "cold laser" nickname.
The light doesn't cut, burn, or sterilize like a surgical laser. Instead it's absorbed by molecules inside cells and may nudge cellular processes that affect inflammation and repair. That's the theory. Whether the theory translates into a dog walking sooner or hurting less is a separate question, and that's where trials matter.
You'll see two broad categories in veterinary clinics. Low-level laser (Class IIIb) uses milliwatts of power and longer treatment times. Class IV therapeutic lasers use several watts, deliver energy faster, and penetrate deeper, but carry a real burn risk if misused. Both are marketed for the same conditions.
The proposed mechanism, in plain terms
The leading explanation is that red and near-infrared light is absorbed by an enzyme in the cell's energy factory (the mitochondria) called cytochrome c oxidase. When that enzyme absorbs light, it may boost the cell's production of ATP, the molecule cells run on, and shift the local chemistry away from inflammation.
Light may also affect nitric oxide and reactive oxygen species, signaling molecules tied to blood flow and inflammation. In animal models and cell cultures, these shifts can speed tissue repair.
The honest caveat: most of this mechanism work comes from petri dishes and rodents, not dogs. A plausible mechanism doesn't guarantee a real-world effect in a 70-pound Labrador with arthritis. The body is messy. Light scatters in skin, gets soaked up by dark fur, and weakens fast as it pushes toward a deep joint. A reaction that looks clean in a flat layer of cells in a lab can fizzle by the time it reaches an actual hip socket under muscle and bone. For deeper background on the cellular side, see our explainer on the science of photobiomodulation and the broader piece on how red light therapy works.
The dog evidence, condition by condition
Veterinary PBM research is smaller and younger than the human literature. Most dog trials enroll a few dozen animals, and several use owner-reported or clinician-scored outcomes rather than hard biological markers. Keep that in mind: even the "positive" trials are modest in size. Below is a summary, then the details.
Evidence summary table
| Condition | Best study type in dogs | What it found | Honest grade |
|---|---|---|---|
| Hip osteoarthritis | Randomized, double-blind, controlled (20 dogs) | PBM improved pain and function scores, with benefits lasting weeks after treatment | Promising, small |
| Elbow osteoarthritis | Randomized, blinded, placebo-controlled (20 dogs) | 9 of 11 PBM dogs cut their NSAID dose vs 0 of 9 sham dogs | Promising, small |
| Spinal surgery (disk herniation) recovery | Two preliminary trials (36 and 24 dogs) | Faster ambulation in one trial; a numerical trend but no statistical significance in another | Mixed |
| TPLO / cruciate surgery recovery | Two randomized trials | Neither showed a significant benefit on pain or function; one saw fewer surgical-site infections, one found control did better on some measures | Negative |
| Open wound healing | Randomized controlled (10 Beagles) | No measurable benefit on wound contraction or healing | Negative |
Osteoarthritis: the strongest signal
Arthritis is where dog PBM has its best evidence, and it's still limited.
A randomized, double-blinded trial in 20 dogs with bilateral hip osteoarthritis compared a three-week course of a Class IV therapeutic laser against a 21-day course of the anti-inflammatory drug meloxicam (PMID 35895799). The laser group showed better pain-severity and function scores at multiple checkpoints out to 30 days, and joint range of motion kept improving from day 15 through day 90. The authors concluded PBM reduced pain and improved clinical findings. Worth noting: this was a comparison against a drug, not against a sham light, so it tells you PBM did something, not exactly how much of that was a true light effect.
The cleaner placebo test comes from elbows. A randomized, blinded, placebo-controlled trial put 20 dogs with naturally occurring elbow arthritis into either real PBM or a sham (0 J/cm²) light, both for six weeks (PMID 30197438). The standout result: 9 of 11 dogs in the laser group were able to lower their NSAID dose, while 0 of 9 dogs in the sham group could (P = 0.0003). Lameness and pain scores also improved more in the laser group. Because the comparison was against a fake light, this is the most credible single piece of dog PBM evidence we have, and it still rests on only 20 dogs at one set of clinics.
Both arthritis trials used doses in the 10 to 20 joules per square centimeter (J/cm²) range. That number matters, and we'll come back to dose.
Spinal cord and disk surgery recovery: mixed
Dogs that herniate a disk (intervertebral disk disease, or IVDD) often need surgery, and PBM has been tested as a recovery add-on.
An early University of Florida study of 36 dogs treated after disk-herniation surgery reported a striking gap: dogs getting laser therapy reached independent walking at a median of 3.5 days, versus 14 days for surgery alone (P = 0.0016) (PMID 22783835). The authors themselves called it a preliminary study, and dogs were assigned by alternating order rather than true randomization, which weakens it.
A later, more rigorous look told a softer story. In 24 dogs treated after thoracolumbar disk surgery, the laser-plus-rehab group reached a better neurological score within 30 days more often than rehab alone (P = 0.04), but the time-to-walk difference, 14.2 days versus 24 days, did not reach statistical significance (P = 0.178) (PMID 32334585). The numbers leaned in PBM's favor, but the study couldn't prove the gap wasn't chance. A separate preliminary trial of PBM plus rehab after hemilaminectomy found no difference in recovery variables between treated and sham dogs at all (PMID 28140641).
Bottom line for spinal recovery: encouraging trends, no slam dunk. The best trials are small and stop short of proving PBM speeds walking.
Orthopedic surgery (TPLO): mixed to negative
When dogs tear a knee ligament (cranial cruciate), a common fix is a procedure called TPLO. Two randomized trials tested PBM during recovery, and they disagree.
One randomized trial of 54 dogs found no statistically significant difference between PBM and sham on pain, weight-bearing, or inflammation (C-reactive protein), whether scored by the clinician or by owners (PMID 38039628). The one hint of an effect: surgical-site infections turned up only in the control group (5 of 30), with none in the laser group. The honest framing from the title itself: "shows promise but no statistically significant difference" on the measured outcomes.
The other trial is a useful reality check. In 12 dogs, low-level laser after TPLO had no beneficial effect on pain or limb function. In fact, the control group had greater ground-reaction forces at weeks 2 and 4 and lower owner-reported pain scores in the early weeks (PMID 30058855). That study used a low dose (about 1.5 to 2.25 J/cm²), far below the arthritis trials, which may explain the flat result, or may simply mean PBM doesn't help here.
Wound healing: largely negative in dogs
Wound healing is where marketing claims run loud and dog data run quiet.
A randomized controlled study created matched wounds on 10 Beagles and treated one side with low-level laser (635 nm, about 1.125 J/cm²) three times a week for 32 days (PMID 26447182). There was no difference between laser and standard care on wound contraction, on how fast skin grew back, or on tissue findings under the microscope. The authors' conclusion was blunt: no apparent beneficial effect on acute wound healing in healthy dogs with that protocol.
A formal systematic review of the dog wound literature reached the same place, finding that across the controlled trials, LLLT showed no reliable benefit on open or incisional wound healing, with only weaker studies hinting at faster healing.
So when a device ad shows a dog's surgical incision and promises faster healing, the dog-specific evidence does not back that up. The dose used in these wound studies was low, which is a fair critique, but lower-dose, well-controlled studies are exactly the ones that came up empty.
Why dose and wavelength make trials hard to compare
A recurring problem in this field: two studies can both call themselves "laser therapy" and deliver wildly different treatments.
The variables that change the actual dose include wavelength (often 635, 660, 810, 830, 850, or 980 nm), power, how long the probe sits on each spot, how far the device is from the skin, and the total energy delivered in J/cm². The arthritis trials that worked used roughly 10 to 20 J/cm². The wound and one TPLO study that flopped used 1 to 2 J/cm². That's a tenfold gap in delivered energy.
There's a known idea in PBM called the biphasic dose response: too little light does nothing, a sweet spot helps, and too much may suppress the very effect you want. If real, it means a "negative" trial might just be underdosed and a clinic's settings could matter as much as whether they own a laser at all. Our guide to red light therapy wavelengths and the piece on dose vs irradiance explain why these numbers are easy to get wrong.
A practical dosing reference table
| Parameter | Common range in dog trials | Why it matters |
|---|---|---|
| Wavelength | 635-980 nm | Longer wavelengths reach deeper tissue; 800-850 nm is typical for joints |
| Dose (radiant exposure) | 1-20 J/cm² | Arthritis benefits clustered at 10-20; under ~2 often showed no effect |
| Sessions | 2-3 per week, then tapering | Most trials ran several weeks, not single sessions |
| Course length | 3-6 weeks | Benefits in arthritis trials sometimes lasted beyond the treatment window |
| Hair/coat | Reduces light reaching skin | Dark, thick coats absorb light; clinics may clip or part fur |
These are study ranges, not a prescription. Settings should come from a veterinarian who can match dose to the dog, the condition, and the device.
Why coat color and body size complicate everything
One under-discussed wrinkle: the same machine settings don't deliver the same dose to every dog. A black Labrador's coat and skin absorb far more light at the surface than a white Poodle's, meaning less energy reaches the target tissue underneath. Thick double coats scatter and block light further still. Some clinics clip or part the fur over the treatment area to compensate, which is a small clue that the staff understands the physics rather than just waving a wand.
Body size matters too. A target joint in a Great Dane sits under more tissue than the same joint in a Chihuahua, so the light has farther to travel and arrives weaker. None of the dog trials were large enough to break results out cleanly by coat color or size, so this stays a reasonable concern rather than a quantified one. But it's a fair reason two dogs getting "the same treatment" might respond very differently.
What a clinic visit actually looks like
If you book a session, the visit is usually short and undramatic. Many dogs tolerate it well and some seem to relax under the warmth of a Class IV unit.
A typical appointment starts with the technician choosing a probe and dose for the condition, then putting protective goggles on the dog (often the brand-name "Doggles" style) and on themselves. The probe is moved slowly over the treatment area, or held on specific points, for anywhere from a couple of minutes to ten or more depending on the device's power and the size of the region. There's no anesthesia, no shaving in most cases, and no recovery time. Dogs walk out and go about their day.
Courses are sold as packages because single sessions rarely do much in the trials. Expect a front-loaded schedule, often two to three visits a week for the first few weeks, then a taper to maintenance. Costs vary widely by region and by whether you're at a general practice, a rehab specialist, or a high-end referral hospital, so it's worth asking for the per-session and package price up front. The same package-pricing dynamics that show up on the human side, covered in our breakdown of home versus professional treatment, apply here too.
How PBM compares with the alternatives
For an arthritic or recovering dog, PBM is rarely the only option, and it's usually best thought of as an add-on rather than a replacement.
NSAIDs (such as carprofen or meloxicam) remain the front-line, evidence-backed treatment for canine arthritis pain. The interesting PBM finding is not that it beats NSAIDs but that it may let some dogs use less of them, which matters for dogs that tolerate the drugs poorly. Newer monoclonal antibody injections for osteoarthritis pain have their own growing evidence base and a different risk profile.
Physical rehabilitation, weight management, and joint supplements are the other mainstays. In several PBM trials, the light was layered on top of rehab, so untangling the laser's solo contribution is genuinely hard. Other physical modalities your vet might mention, including acupuncture, therapeutic ultrasound, shockwave, and pulsed electromagnetic field therapy, sit in roughly the same evidence tier: some support, not definitive. The 2022 AAHA Pain Management Guidelines for Dogs and Cats group these together as rehabilitation options with some supporting evidence (PMID 35195712).
If you're weighing the human-device parallels, our comparisons of panels versus full-body beds and the realities of home versus professional treatment cover the same trade-offs that show up in the veterinary world.
Safety: what owners should actually watch for
Veterinary PBM is generally considered low-risk when done correctly, and adverse events in the published dog trials were rare. But "low-risk" is not "no-risk," and a few cautions are real.
The single biggest hazard is the eyes. Laser light, especially from Class IV devices, can damage the retina. Both the dog and every human in the room should wear wavelength-appropriate goggles, and the beam should never be aimed at or near the eyes. Our human-side write-up on eye safety and goggles explains why this isn't optional.
Higher-power Class IV lasers can also burn skin if the probe lingers too long in one spot, if the dose is set too high, or on dark or tattooed skin that absorbs more light. This is an operator-skill issue, which is one argument for treatment by trained staff rather than an untested home gadget pointed at your pet.
A few groups warrant extra caution or avoidance: treating directly over a known or suspected tumor (light could theoretically affect cell activity), over the pregnant uterus, over the thyroid gland, over open growth plates in very young animals, and over recent injection sites of certain medications. These are precautionary, not all proven harmful, but they're standard contraindications a good clinic will respect. Anyone considering it should also know that PBM is an adjunct, never a substitute for diagnosing why a dog is in pain.
Regulation: what "FDA cleared" means for these devices
Therapeutic laser units sold to veterinary clinics are regulated by the FDA as medical devices, and many carry 510(k) clearance, which you can look up in the public FDA device database.
Here's the part owners miss: 510(k) clearance means the device is "substantially equivalent" to something already on the market and is safe to sell. It is not proof the device cures a given condition in dogs. Clearance is about the machine, not about a clinical claim for your pet's arthritis. A cleared laser and an effective treatment are two different bars, and only one of them is set by trials. To go deeper on this distinction, see what 510(k) clearance actually means.
You can scan the broader veterinary and human literature yourself through a PubMed search for photobiomodulation in dogs, which is the same place the trials cited here live.
Who it's reasonable for, and who should skip it
Red light therapy is a reasonable thing to discuss with your vet if your dog has osteoarthritis, especially in the hips or elbows, and you want a low-risk add-on that might let you trim NSAID doses. The arthritis evidence, while small, is the most encouraging in the whole field.
It's also a defensible add-on during recovery from spinal disk surgery, where trends favor it even if the proof isn't airtight. Just go in clear-eyed that you may be paying for a modest or uncertain benefit.
Be more skeptical if a clinic or product pitches PBM for faster wound or incision healing in an otherwise healthy dog, since the controlled dog data there is essentially flat. And steer clear entirely of using any laser device over a tumor, a pregnant belly, or near the eyes without protection and professional supervision.
The fair summary: PBM for dogs is promising in arthritis, mixed in surgical recovery, and unproven-to-negative for wound healing, with dose and wavelength likely explaining a lot of the disagreement. It's a sensible adjunct, not a cure, and the honest evidence supports it as such.
Frequently Asked Questions
Does red light therapy actually work for dogs with arthritis?
The best dog evidence is for arthritis, and it's cautiously positive. A blinded, placebo-controlled trial in elbow arthritis found 9 of 11 treated dogs could lower their pain-medication dose versus none in the sham group, and a hip-arthritis trial showed improved pain and function scores. Both studies were small, around 20 dogs, so treat this as promising rather than proven.
Is laser therapy for dogs the same as red light therapy?
Yes, in practice. Veterinary "laser therapy," "cold laser," "low-level laser therapy," and "photobiomodulation" all describe red or near-infrared light aimed at tissue to reduce pain and aid healing. The main difference is power: low-level (Class IIIb) units are gentler and slower, while Class IV lasers are stronger, faster, and carry a higher burn risk if misused.
Is red light or laser therapy safe for my dog?
It's generally low-risk when done by trained staff with proper eye protection for the dog and humans. The real hazards are retinal damage from looking into the beam and skin burns from high-power lasers held too long in one spot. It should be avoided over tumors, the pregnant uterus, and the thyroid, and it never replaces a proper diagnosis of why your dog hurts.
How many laser therapy sessions will my dog need?
The trials that showed benefit generally ran two to three sessions per week over three to six weeks, not a single visit. In the arthritis studies, some improvements lasted weeks beyond the treatment course. Your vet should set the schedule based on the condition and the device, and you shouldn't expect overnight results.
Why do some studies say red light therapy doesn't work for dogs?
Mostly because of dose. The dog studies that found no benefit, especially for wound healing and one knee-surgery trial, used low energy doses of roughly 1 to 2 J/cm², while the arthritis trials that worked used about 10 to 20 J/cm². Different wavelengths, coat thickness, and treatment times add more noise, making "laser therapy" studies genuinely hard to compare head to head.
This article is for general education and is not veterinary advice. Always consult a licensed veterinarian before starting any therapy for your pet.